Bioinnovation Institute wants to boost women's health research: "It hasn't been prestigious enough"

With the hiring of Trine Bartholdy as new chief innovation officer at Bioinnovation Institute, the life science incubator wants to put research into women's health at center stage. The area is almost paradoxially underprioritized by the investment environment and the industry at large, but the economic potential is nonetheless considerable, Bartholdy says.

Trine Bartholdy, Chief Innovation Office at Bioinnovation Institute | Photo: Bioinnovation Institute Fonden / PR

Despite women making up half of the world's population, an increasingly smaller sum of the many billions of dollars spent on the research and development of new drugs goes to diseases related specifically to women.

This paradox is now being highlighted by Bioinnovation Institute (BII), which supports early-stage life science start-ups from its headquarters in biotech hub COBIS, located in Copenhagen. The company is now seeking to correct this incongruity by aiding the area.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs